These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1093 related articles for article (PubMed ID: 26278673)

  • 1. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment.
    Ishii G; Ochiai A; Neri S
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):186-196. PubMed ID: 26278673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAFs and TAMs: maestros of the tumour microenvironment.
    Komohara Y; Takeya M
    J Pathol; 2017 Feb; 241(3):313-315. PubMed ID: 27753093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
    Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
    Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
    Patel AK; Singh S
    Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
    Sazeides C; Le A
    Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
    Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
    Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SnapShot: Cancer-Associated Fibroblasts.
    Park D; Sahai E; Rullan A
    Cell; 2020 Apr; 181(2):486-486.e1. PubMed ID: 32302576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organoid culture containing cancer cells and stromal cells reveals that podoplanin-positive cancer-associated fibroblasts enhance proliferation of lung cancer cells.
    Nakamura H; Sugano M; Miyashita T; Hashimoto H; Ochiai A; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2019 Aug; 134():100-107. PubMed ID: 31319967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small role with big impact: miRNAs as communicators in the cross-talk between cancer-associated fibroblasts and cancer cells.
    Wang Z; Tan Y; Yu W; Zheng S; Zhang S; Sun L; Ding K
    Int J Biol Sci; 2017; 13(3):339-348. PubMed ID: 28367098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
    González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
    Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblasts in cancer: Defining target structures for therapeutic intervention.
    Boesch M; Baty F; Rumpold H; Sopper S; Wolf D; Brutsche MH
    Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):111-121. PubMed ID: 31265878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
    Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
    Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts.
    Mezawa Y; Orimo A
    FEBS J; 2022 May; 289(9):2429-2447. PubMed ID: 33786982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
    Yoshida GJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.
    Bu L; Baba H; Yoshida N; Miyake K; Yasuda T; Uchihara T; Tan P; Ishimoto T
    Oncogene; 2019 Jun; 38(25):4887-4901. PubMed ID: 30816343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell analysis on stromal fibroblasts in the microenvironment of solid tumours.
    Musa M
    Adv Med Sci; 2020 Mar; 65(1):163-169. PubMed ID: 31972467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.
    Corsa CA; Brenot A; Grither WR; Van Hove S; Loza AJ; Zhang K; Ponik SM; Liu Y; DeNardo DG; Eliceiri KW; Keely PJ; Longmore GD
    Cell Rep; 2016 Jun; 15(11):2510-23. PubMed ID: 27264173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts in hepatocellular carcinoma.
    Kubo N; Araki K; Kuwano H; Shirabe K
    World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.